GLP1R boosts survival, migration and invasion of endometrial cancer cells and protects against ferroptotic cell death

References

• Arend, R. C., et al., 2018. Endometrial cancer: Molecular markers and management of advanced stage disease. Gynecologic Oncology, 150 (3), 569–580.
   PubMed Web of Science ®Google Scholar
• Ast, J., et al., 2020. Super-resolution microscopy compatible fluorescent probes reveal endogenous glucagon-like peptide-1 receptor distribution and dynamics. Nature Communications, 11 (1), 5160.
   PubMed Web of Science ®Google Scholar
• Bakkum-Gamez, J. N., et al., 2014. Efficacy of contemporary chemotherapy in stage IIIC endometrial cancer: A histologic dichotomy. Gynecologic Oncology, 132 (3), 578–584.
   PubMed Web of Science ®Google Scholar
• Bogani, G., et al., 2019. Low-volume disease in endometrial cancer: the role of micrometastasis and isolated tumor cells. Gynecologic Oncology, 153 (3), 670–675.
   PubMed Web of Science ®Google Scholar
• Carugno, J., et al., 2021. New development on hysteroscopy for endometrial cancer diagnosis: State of the art. Minerva Medica, 112 (1), 12–19.
   PubMed Web of Science ®Google Scholar
• Cases, A. I., et al., 2015. Significance of expression of glucagon-like peptide 1 receptor in pancreatic cancer. Oncology Reports, 34 (4), 1717–1725.
   PubMed Web of Science ®Google Scholar
• Casey, L. and Singh, N., 2020. Metastases to the ovary arising from endometrial, cervical and fallopian tube cancer: recent advances. Histopathology, 76 (1), 37–51.
   PubMed Web of Science ®Google Scholar
• Chen, L., et al., 2021. Characterization of interplay between autophagy and ferroptosis and their synergistical roles on manipulating immunological tumor microenvironment in squamous cell carcinomas. Frontiers in Immunology, 12, 739039.
   PubMed Web of Science ®Google Scholar
• Chikayo, I., et al., 2017. Exendin-4, a glucagon-like peptide-1 receptor agonist, attenuates breast cancer growth by inhibiting NF-κB activation. Endocrinology, (12), 4218.
   Google Scholar
• Forsse, D., et al., 2020. Maintained survival outcome after reducing lymphadenectomy rates and optimizing adjuvant treatment in endometrial cancer. Gynecologic Oncology, 160 (2), 396–404.
   PubMed Web of Science ®Google Scholar
• He, W., et al., 2016. Exendin-4 inhibits growth and augments apoptosis of ovarian cancer cells. Molecular and Cellular Endocrinology, 436, 240–249.
   PubMed Web of Science ®Google Scholar
• Jones, B., et al., 2018. Targeting GLP-1 receptor trafficking to improve agonist efficacy. Nature Communications, 9 (1), 1602.
   PubMedGoogle Scholar
• Kanda, R., et al., 2018. Expression of the glucagon-like peptide-1 receptor and its role in regulating autophagy in endometrial cancer. BMC Cancer, 18 (1), 657.
   PubMedGoogle Scholar
• Koehler, J. A., Kain, T. and Drucker, D. J., 2011. Glucagon-like peptide-1 receptor activation inhibits growth and augments apoptosis in murine CT26 colon cancer cells. Endocrinology, 152 (9), 3362–3372.
   PubMed Web of Science ®Google Scholar
• Lees, B., et al., 2021. A population-based study of causes of death after endometrial cancer according to major risk factors. Gynecologic Oncology, 160 (3), 655–659.
   PubMed Web of Science ®Google Scholar
• Li, X. N., et al., 2017. Glucagon-like peptide-1 analogues inhibit proliferation and increase apoptosis of human prostate cancer cells in vitro. Experimental and Clinical Endocrinology & Diabetes: Official Journal, German Society of Endocrinology [and] German Diabetes Association, 125 (2), 91–97.
   PubMed Web of Science ®Google Scholar
• Liang, C., et al., 2019. Recent progress in ferroptosis inducers for cancer therapy. Advanced Materials, 31 (51), e1904197.
   PubMed Web of Science ®Google Scholar
• Mahecha, A. M., and Wang, H., 2017. The influence of vascular endothelial growth factor-A and matrix metalloproteinase-2 and -9 in angiogenesis, metastasis, and prognosis of endometrial cancer. OncoTargets & Therapy, 10, 4617–4624.
   PubMed Web of Science ®Google Scholar
• Mali, A. V., et al., 2019. Anticancer and antimetastatic potential of enterolactone: clinical, preclinical and mechanistic perspectives. European Journal of Pharmacology, 852, 107–124.
   PubMed Web of Science ®Google Scholar
• Matsuo, K., et al., 2021. Ovarian conservation for young women with early-stage, low-grade endometrial cancer: a 2-step schema. American Journal of Obstetrics and Gynecology, 224 (6), 574–584.
   PubMed Web of Science ®Google Scholar
• Moro, F., et al., 2019. Synchronous primary cancers of endometrium and ovary vs endometrial cancer with ovarian metastasis: an observational study. Ultrasound in Obstetrics & Gynecology, 53 (6), 827–835.
   PubMed Web of Science ®Google Scholar
• Murali, R., et al., 2018. Evolving roles of histologic evaluation and molecular/genomic profiling in the management of endometrial cancer. Journal of the National Comprehensive Cancer Network: Jnccn, 16 (2), 201–209.
   PubMed Web of Science ®Google Scholar
• Nie, Z. J., et al., 2018. Exendin-4 inhibits glioma cell migration, invasion and epithelial-to-mesenchymal transition through GLP-1R/sirt3 pathway. Biomedicine and Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 106, 1364–1369.
   PubMed Web of Science ®Google Scholar
• Paola, L., et al., 2013. Exendin-4 induces cell adhesion and differentiation and counteracts the invasive potential of human neuroblastoma cells. Plos One, 8 (8), 903–906.
   Web of Science ®Google Scholar
• Kito, M., et al., 2015. CRP 1846C > T genetic polymorphism is associated with lymph node metastasis and/or severe lymphatic invasion in endometrial cancer. The Tohoku Journal of Experimental Medicine, 237, 25–30.
   PubMed Web of Science ®Google Scholar
• Shigeoka, T., et al., 2020. Activation of overexpressed GLP attenuates prostate cancer growth by inhibiting cell cycle progression. Journal of Diabetes Investigation, 11 (5), 1137–1149.
   PubMed Web of Science ®Google Scholar
• Sobecki-Rausch, J. and Barroilhet, L., 2019. Anti-programmed death-1 immunotherapy for endometrial cancer with microsatellite instability–high tumors. Current Treatment Options in Oncology, 20 (11), 83.
   PubMed Web of Science ®Google Scholar
• Su, Y., et al., 2020. Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs. Cancer Letters, 483, 127–136.
   PubMed Web of Science ®Google Scholar
• Suzuki, K., et al., 2019. Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population. Nature Genetics, 51 (3), 379–386. (Suppl 1).
   PubMed Web of Science ®Google Scholar
• Timper, K., et al., 2020. GLP-1 receptor signaling in astrocytes regulates fatty acid oxidation, mitochondrial integrity, and function. Cell Metabolism, 31 (6), 1189–1205.e13.
   PubMed Web of Science ®Google Scholar
• Vetter, M. H., et al., 2019. Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasia. Autonomic Neuroscience: basic & Clinical, 222, 60.e1–60.e7.
   Google Scholar
• Wang, H., et al., 2021. Silencing of PTPN18 induced ferroptosis in endometrial cancer cells through p-P38-mediated GPX4/xCT down-regulation. Cancer Management and Research, 13, 1757–1765.
   PubMed Web of Science ®Google Scholar
• Xiao, Y., et al., 2021. Inhibition of PFKFB3 induces cell death and synergistically enhances chemosensitivity in endometrial cancer. Oncogene, 40 (8), 1409–1424.
   PubMed Web of Science ®Google Scholar
• Xing, N. A., et al., 2022. Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC.
   Google Scholar
• Zhao, H. J., et al., 2020. Activation of GLP-1 receptor enhances the chemosensitivity of pancreatic cancer cells. Journal of Molecular Endocrinology, 64 (2), 103–113.
   PubMed Web of Science ®Google Scholar
• Zhao, H., et al., 2014. Activation of glucagon-like peptide-1 receptor inhibits growth and promotes apoptosis of human pancreatic cancer cells in a cAMP-dependent manner. American Journal of Physiology. Endocrinology and Metabolism, 306 (12), E1431–E1441.
   PubMed Web of Science ®Google Scholar
• Zhou, W. J., et al., 2019. Estrogen inhibits autophagy and promotes growth of endometrial cancer by promoting glutamine metabolism. Cell Communication and Signaling, 17 (1), 99.
   PubMed Web of Science ®Google Scholar
• Zhu, X., et al., 2019. EMT-mediated acquired EGFR-TKI resistance in NSCLC: mechanisms and strategies. Frontiers in Oncology, 9, 1044.
   PubMed Web of Science ®Google Scholar